SW

Scott Whitcup

Founder and CEO at Akrivista

Irvine, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Clinical Development
Ophthalmology
Clinical Trials
Pharmaceutical Industry
Dermatology
Immunology
Clinical Research
Medical Devices
Medical Affairs
FDA
Urology
R&D
Surgery
Internal Medicine
Oncology
CRO
Drug Development
GCP
Therapeutic Areas
Regulatory Submissions

Education

Work Experience

Akrivista and Whitecap Biosciences

2015

  • Founder and CEO

    2015

    Akrivista is a company focused on developing novel therapies in ophthalmology.

Allergan

2000 - 2015

  • EVP, R&D

    2004 - 2015

  • Head, Ophthalmology Therapeutic Area

    2000 - 2004

National Eye Institute (NEI)

1993 - 2000

  • Clinical Director

    1993 - 2000

National Eye Institute (NEI)

1990 - 1992

  • Clinical Fellow

    1990 - 1992

    Fellowship in Uveitis and Ocular Immunology

Massachussets Eye and Ear Infirmary-Harvard Medical School

1987 - 1990

  • Ophthalmology Resident

    1987 - 1990

    Residency in Ophthalmology

UCLA Medical Center

1984 - 1987

  • Internal Medicine Resident

    1984 - 1987

    Residency in Internal Medicine